The Impact of Recombinant Technologies in Understanding Plasma Proteins Important for Hemostasis and Thrombosis
It is clear that the power of molecular biology technology (1) has provided enormous access to information about molecular structure; (2) has provided access to biological problems which were formerly inaccessible; (3) has provided materials and resources for the management of human biology and the treatment of disease. Today, we truly have access to molecular pharmacology. We can modify molecules; we can create new molecules. We have the capacity for industrial scale production of otherwise scarce natural products. In the next decade the understanding of the transcriptional control of the gene and the translational control of message, as well as the trafficking of protein of cells, will become accessible through the technologies of molecular biology.
KeywordsFactor VIII Factor Versus Industrial Laboratory Recombinant Technology Genetic Institute
Unable to display preview. Download preview PDF.
- 5.Fass, D.N., Hewick, R., Knutson, G.J., Nesheim, M., Mann, K. 1983. Thromb. Haemostasis 50: 255.Google Scholar
- 14.Bright, R. 1836. Guys Hospital Report. 1: 338–379.Google Scholar
- 15.Mikake, T., Kung, C.K.H. and Goldwasser, E. 1977. J. Biol. Chem. 252: 558–564.Google Scholar